Enhancement of antibiotic susceptibility of stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump

Canadian Journal of Microbiology

Volumn 57, Issue 10, 2011, Pages 820-828

  Al Hamad, Arif ^a,b   Burnie, James ^a   Upton, Mathew ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b QATIF CENTRAL HOSPITAL   (Saudi Arabia)

Author keywords

ABC transporter; Antibody based therapy; Multidrug resistance; Stenotrophomonas maltophilia

Indexed keywords

ABC TRANSPORTER; ADDITIVE EFFECTS; ANTIBODY-BASED THERAPY; ANTIMICROBIAL RESISTANCES; ATP-BINDING CASSETTE; BROAD SPECTRUM ANTIBIOTICS; CIPROFLOXACIN; CLINICAL STRAINS; DRUG COMPOUNDS; EFFLUX PUMPS; GROWTH CURVES; IN-VITRO; INTRINSIC RESISTANCE; KINETIC STUDY; MULTIDRUG EFFLUX; MULTIDRUG RESISTANCE; NOSOCOMIAL PATHOGENS; POLYCLONAL ANTIBODY; STENOTROPHOMONAS MALTOPHILIA; SUBSTRATE RECOGNITION SITES;

ANTIBIOTICS; BACTERIOLOGY; HEALTH CARE; STRAIN;

ANTIBODIES;

CIPROFLOXACIN; COTRIMOXAZOLE; POLYCLONAL ANTIBODY; TIMENTIN;

ANTIBODY; ANTIMICROBIAL ACTIVITY; BACTERIUM; DRUG RESISTANCE; INHIBITION; KINETIC ENERGY; SUBSTRATE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GROWTH CURVE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ATP-BINDING CASSETTE TRANSPORTERS; CIPROFLOXACIN; CLAVULANIC ACIDS; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; RABBITS; STENOTROPHOMONAS MALTOPHILIA; TICARCILLIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

STENOTROPHOMONAS MALTOPHILIA;

EID: 80053240132     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/w11-076     Document Type: Article

References (38)

1. Al-Hamad, A., Upton, M., and Burnie, J. 2009. Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 64(4): 731-734. doi:10.1093/jac/dkp271.
2. Alonso, A., and Martinez, J. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41(5): 1140-1142.
3. Alonso, A., and Martinez, J. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44(11): 3079-3086. doi:10.1128/AAC.44.11.3079-3086.2000.
4. American Society for Microbiology. 2011. Antimicrobial agents and chemotherapy: 2011 instructions to authors. Antimicrob. Agents Chemother. 55(1): 1-23. doi:10.1128/AAC.01281-10.
5. Bajaksouzian, S., Visalli, M., Jacobs, M., and Appelbaum, P. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41(5): 1073-1076.
6. Baker, C.J., Melish, M.E., Hall, R.T., Casto, D.T., Vasan, U., Givner, L.B., et al. 1992. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N. Engl. J. Med. 327(4): 213-219. doi:10.1056/NEJM199207233270401.
7. Chen, C.-j., Chin, J.E., Ueda, K., Clark, D.P., Pastan, I., Gottesman, M.M., and Roninson, I.B. 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47(3): 381-389. doi:10.1016/0092-8674(86)90595-7.
8. Chirico, G., Rondini, G., Plebani, A., Chiara, A., Massa, M., and Ugazio, A. 1987. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J. Pediatr. 110(3): 437-442. doi:10.1016/S0022-3476(87)80514-0.
9. Clark, N.M., Patterson, J., and Lynch, J.P., III. 2003. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr. Opin. Crit. Care, 9(5): 413-423. doi:10.1097/00075198-200310000-00012.
10. Crossman, L.C., Gould, V.C., Dow, J.M., Vernikos, G.S., Okazaki, A., Sebaihia, M., et al. 2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9(4): R74. doi:10.1186/gb-2008-9-4-r74.
11. Davidson, A.L., Dassa, E., Orelle, C., and Chen, J. 2008. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol. Mol. Biol. Rev. 72(2): 317-364. doi:10.1128/MMBR.00031-07.
12. Denton, M., and Kerr, K. 1998. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11(1): 57-80.
13. Dobrovetsky, E., Menendez, J., Edwards, A., and Koth, C. 2007. A robust purification strategy to accelerate membrane proteomics. Methods, 41(4): 381-387. doi:10.1016/j.ymeth.2006.08.009.
14. European Committee for Antimicrobial Susceptibility Testing. 2000. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect. 6(9): 503-508.
15. Falagas, M.E., Valkimadi, P.E., Huang, Y.T., Matthaiou, D.K., and Hsueh, P.R. 2008. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J. Antimicrob. Chemother. 62(5): 889-894. doi:10.1093/jac/dkn301.
16. Fath, M., and Kolter, R. 1993. ABC transporters: bacterial exporters. Microbiol. Rev. 57(4): 995-1017.
17. Holland, I.B., and Blight, M.A. 1999. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293(2): 381-399. doi:10.1006/jmbi.1999.2993.
18. Huda, N., Lee, E., Chen, J., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. 2003. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47(8): 2413-2417. doi:10.1128/AAC.47.8.2413-2417.2003.
19. Kimura, Y., Morita, S.-y., Matsuo, M., and Ueda, K. 2007. Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci. 98(9): 1303-1310. doi:10.1111/j.1349-7006.2007.00538.x.
20. Looney, W.J., Narita, M., and Mühlemann, K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9(5): 312-323. doi:10.1016/S1473-3099(09) 70083-0.
21. Micozzi, A., Venditti, M., Monaco, M., Friedrich, A., Taglietti, F., Santilli, S., and Martino, P. 2000. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin. Infect. Dis. 31(3): 705-711. doi:10.1086/314043.
22. Morrison, A.J., Jr, Hoffmann, K.K., and Wenzel, R.P. 1986. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J. Clin. Microbiol. 24(1): 52-55.
23. Nicodemo, A.C., and Paez, J.I. 2007. Antimicrobial herapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26(4): 229-237. doi:10.1007/s10096-007-0279-3.
24. O'Neill, A.J., Bostock, J.M., Moita, A.M., and Chopra, I. 2002. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J. Antimicrob. Chemother. 50(6): 839-848. doi:10.1093/jac/dkf248.
25. Pagès, J.-M., Masi, M., and Barbe, J. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11(8): 382-389. doi:10.1016/j.molmed.2005.06.006.
26. Pillai, S., Moellering, R.J., and Eliopoulos, G. 2005. Antimicrobial combinations. In Antibiotics in laboratory medicine. Edited by V. Lorian. Williams & Wilkins, Baltimore, Md., USA. pp. 365-440.
27. Saiman, L., Mehar, F., Niu, W.W., Neu, H., Shaw, K., Miller, G., and Prince, A. 1996. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin. Infect. Dis. 23(3): 532-537. doi:10.1093/clinids/23.3.532.
28. Senol, E. 2004. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J. Hosp. Infect. 57(1): 1-7. doi:10.1016/j.jhin.2004.01.033.
29. Senol, E., DesJardin, J., Stark, P., Barefoot, L., and Snydman, D. 2002. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin. Infect. Dis. 34(12): 1653-1656. doi:10.1086/340707.
30. Stratta, R., Shaefer, M., Cushing, K., Markin, R., Reed, E., Langnas, A., et al. 1992. A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch. Surg. 127(1): 55-64.
31. The Intravenous Immunoglobulin Collaborative Study Group. 1992. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N. Engl. J. Med. 327(4): 234-240. doi:10.1056/NEJM199207233270404.
32. Valdezate, S., Vindel, A., Loza, E., Baquero, F., and Canton, R. 2001. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob. Agents Chemother. 45(5): 1581-1584. doi:10.1128/AAC.45.5.1581-1584.2001.
33. van Veen, H.W., Venema, K., Bolhuis, H., Oussenko, I., Kok, J., Poolman, B., et al. 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. U.S.A. 93(20): 10 668-10 672. doi:10.1073/pnas.93.20.10668.
34. Vartivarian, S., Anaissie, E., Bodey, G., Sprigg, H., and Rolston, K. 1994. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38(3): 624-627.
35. Walsh, T.R., Hall, L., Assinder, S.J., Nichols, W.W., Cartwright, S.J., MacGowan, A.P., and Bennett, P.M. 1994. Sequence analysis of the L1 metallo-b-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta, 1218(2): 199-201.
36. Walsh, T.R., MacGowan, A.P., and Bennett, P.M. 1997. Sequence analysis and enzyme kinetics of the L2 serine b-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41(7): 1460-1464.
37. Whitby, P., Carter, K., Burns, J., Royall, J., LiPuma, J.J., and Stull, T. L. 2000. Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J. Clin. Microbiol. 38(12): 4305-4309.
38. Zgurskaya, H.I. 2002. Molecular analysis of efflux pump-based antibiotic resistance. Int. J. Med. Microbiol. 292(2): 95-105. doi:10.1078/1438-4221-00195.